Media

Journalistin-Stimmung Medien

Media Services

Tel.: +41 58 469 92 11 

communication@ivi.admin.ch

What’s new

In vitro Zoo helps in understanding Sars-CoV-2 (PDF, 87 kB, 19.07.2021)A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) have used a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals to determine which animals are susceptibly to SARS-CoV-2 infection.

BioCopy Holding AG and Institute of Virology and Immunology (IVI) announce collaboration on African swine fever (PDF, 103 kB, 21.04.2021)BioCopy Holding AG and the Institute of Virology and Immunology (IVI) have announced to collaborate in researching a vaccine and developing new diagnostic methods in the fight against African swine fever (ASF). Fatal to pigs and wild boar, the ASF virus reached Eastern Germany in 2020 after circulating in Eastern Europe for many years.

Why SARS-CoV-2 replicates better in the upper respiratory tract (PDF, 118 kB, 27.04.2021)A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular defense mechanisms in the respiratory tract. They have shown that natural temperature differences that exist in the upper and lower respiratory tract have a profound influence on SARS-CoV-2 replication and subsequent innate immune activation in human cells. The findings can help to develop antiviral drugs and preventive measures.

SARS-CoV-2 mutations in competition (PDF, 157 kB, 21.04.2021)How dangerous are new mutations of the SARS-CoV-2 virus? An international team involving researchers from the Institute of Virology and Immunology (IVI) of the Federal Food Safety and Veterinary Office BLV and the University of Bern (Switzerland), the Centers for Disease Control and Prevention (USA), and the Friedrich-Loeffler Institute (Germany), has developed an approach that can accurately assess the transmissibility of new virus mutants.

Last modification 20.07.2021

Top of page

https://www.ivi.admin.ch/content/ivi/en/home/das-ivi/medien.html